New Mexico pauses Johnson & Johnson COVID-19 vaccine distribution

New Mexico

This Dec. 2, 2020 photo provided by Johnson & Johnson shows vials of the COVID-19 vaccine in the United States. The nation is poised to get a third vaccine against COVID-19, but health officials are concerned that at first glance the Johnson & Johnson shot may not be seen as equal to other options from Pfizer and Moderna. (Johnson & Johnson via AP)

SANTA FE, N.M. (KAMR/KCIT) – The New Mexico Department of Health has announced that Johnson & Johnson COVID vaccine distribution will be paused following federal Center for Disease Control and Food and Drug Administration recommendations.

Said the statement:

These announcements follow reports of six “rare and severe” blood clots – out of 6.8 million doses given – among women between the ages of 18 and 48 in the United States. Symptoms occurred 6 to 13 days after vaccination.  

“New Mexico – like the federal government – is acting out of an abundance of caution,” said DOH Secretary Dr. Tracie Collins. “As we learn more, we will share that information.” 

Scheduled J&J events and vaccinations will be paused or shifted to Pfizer and Moderna.

People who have received the J&J vaccine who develop severe headache, blurred vision, seizure, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider. Health care providers should report adverse events to the Vaccine Adverse Events Reporting System at Please note: these adverse events are extremely rare – less than one per million.

More from

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Video Forecast

More Forecast

Don't Miss